Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out the toxicities of doxercalciferol given in
combination with docetaxel (Taxotere®), as well as to see how well this combination works in
the treatment of prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborators:
Genzyme, a Sanofi Company Sanofi
Treatments:
1 alpha-hydroxyergocalciferol Dihydroxycholecalciferols Docetaxel Ergocalciferols Hydroxycholecalciferols Vitamin D